Durovis - Dive Board

Dive Board

« Previous
1
Next »

How Do Immunomodulatory Agents Support COVID-19 Treatment?

by Application of Green Reagents in Pharmaceutical Synthesis on Apr 15th, 2025 09:55 AM

[size=2][font=Verdana, Arial, Helvetica, sans-serif]COVID-19 induces hyperinflammatory responses, necessitating immunomodulatory agents to mitigate excessive immune reactions.[/font][/size]
[size=3][font=MontserratRegular, Arial, sans-serif, serif][b]Corticosteroids (Dexamethasone)[/b][/font][/size]
[color=#233ca1]Dexamethasone[/color] is widely used to reduce inflammation in severe COVID-19 cases, particularly in patients requiring oxygen therapy or mechanical ventilation. It helps decrease mortality rates by modulating cytokine storm effects.
[size=3][font=MontserratRegular, Arial, sans-serif, serif][b]Baricitinib (Olumiant)[/b][/font][/size]
[size=3][font=MontserratRegular, Arial, sans-serif, serif]Baricitinib[/font][/size], a Janus kinase (JAK) inhibitor, reduces inflammation by blocking the JAK-STAT signaling pathway. It is administered orally in hospitalized patients requiring supplemental oxygen or non-invasive ventilation.

Application of Green Reagents in Pharmaceutical Synthesis

Posts: 4

Joined: 11.04.2025

Re: How Do Immunomodulatory Agents Support COVID-19 Treatment?

by Jovie Louise on Apr 16th, 2025 12:28 PM

[color=#333333][size=1][font=Verdana]Immunomodulatory agents have played a crucial role in my understanding of COVID-19 treatment. These agents help regulate the immune response, reducing inflammation and preventing overreaction in severe cases. I’ve [/font][/size][/color][color=#333333][size=1][font=Verdana]nursing home Los Angeles [/font][/size][/color][color=#333333][size=1][font=Verdana]seen how they support recovery by balancing the body’s immune function, particularly in managing complications like cytokine storms during infection.[/font][/size][/color]

Jovie Louise

Posts: 15

Joined: 17.01.2025